On March 20. 2025 (local time), the 2025 DCAT Week concluded successfully in New York, USA. As a global CDMO service provider, Laviana Pharma once again became the focus of the industry with its outstanding technological strength and forward-looking strategic layout. This global event, hosted by the Drug, Chemical & Associated Technologies Association (DCAT), attracted many biopharmaceutical and upstream and downstream companies to discuss innovation and sustainable development in the industry chain.

In the spring, everything flourishes. On March 12, this hopeful International Arbor Day, Laviana Pharma (Cangzhou) Co., Ltd. initiated a public welfare tree planting campaign themed 'Building a Green Home Together, Practicing Corporate Responsibility.' This event not only reflects Laviana Pharma's steadfast commitment to environmental protection but also signifies a profound commitment to sustainable development, low-carbon environmental stewardship, and public welfare under the guidance of ESG (Environmental, Social, and Governance) principles.

Recently, the Cangzhou Lin'gang Industrial Park in Hebei held a mobilization and summary commendation meeting for high-quality development in 2025. grandly honoring enterprises that have made outstanding contributions to the park's development. Laviana Pharma  (Cangzhou) Co., Ltd., as an invited enterprise, attended the meeting and witnessed this grand event alongside over 200 other enterprises.

Recently, in accordance with the 'Administrative Measures for the Recognition of High-tech Enterprises' (Guo Ke Fa Huo [2016] No. 32) and the 'Guidelines for the Recognition of High-tech Enterprises' (Guo Ke Fa Huo [2016] No. 195), the Jiangsu Province recognition agency has announced the third batch of record filing lists for high-tech enterprises recognized in 2024. Following its designation as a 'High-tech Enterprise' in 2021, Laviana Pharma (Jiangsu) Co., Ltd. has successfully achieved high-tech enterprise recognition once again in Jiangsu Province.

Recently, Laviana Pharma various branches held a ceremony to mark the auspicious start of operations in 2025. officially sounding the “charge” for the new year. As an innovative pharmaceutical R&D and production service (CDMO) enterprise, Laviana Pharma aims to become a professional CDMO flagship company, fully deploying its New Year strategy to accelerate technological upgrades and international expansion, providing efficient and sustainable one-stop services for global pharmaceutical companies.

As the year transitions and the days and months illuminate our path, we find ourselves at this beautiful juncture of bidding farewell to the old and embracing the new. Laviana Pharma extends its utmost respect to all employees who have diligently contributed to the company over the past year. We would like to express our profound gratitude to the families of all Lewei employees who have provided unwavering support. Furthermore, we extend our sincerest New Year greetings to our global partners and friends from various sectors who have consistently cared for and supported Laviana Pharma.